Find Sodium Zirconium Cyclosilicate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Uzsi 9, Zs-9 compound, Uzsi-9, Unii-d652zwf066, Zs 9
Molecular Formula
H6Na2O9Si3Zr+2
Molecular Weight
371.50  g/mol
InChI Key
CBTCHTJSGLCFMY-UHFFFAOYSA-N

Sodium Zirconium Cyclosilicate
1 2D Structure

Sodium Zirconium Cyclosilicate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
disodium;2,2,4,4,6,6-hexahydroxy-1,3,5,2,4,6-trioxatrisilinane;zirconium
2.1.2 InChI
InChI=1S/2Na.H6O9Si3.Zr/c;;1-10(2)7-11(3,4)9-12(5,6)8-10;/h;;1-6H;/q2*+1;;
2.1.3 InChI Key
CBTCHTJSGLCFMY-UHFFFAOYSA-N
2.1.4 Canonical SMILES
O[Si]1(O[Si](O[Si](O1)(O)O)(O)O)O.[Na+].[Na+].[Zr]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Lokelma

2. Sodium Zirconium Cyclosilicate

3. Zs-9 Compound

2.2.2 Depositor-Supplied Synonyms

1. Uzsi 9

2. Zs-9 Compound

3. Uzsi-9

4. Unii-d652zwf066

5. Zs 9

2.3 Create Date
2015-06-06
3 Chemical and Physical Properties
Molecular Weight 371.50 g/mol
Molecular Formula H6Na2O9Si3Zr+2
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count9
Rotatable Bond Count0
Exact Mass369.816199 g/mol
Monoisotopic Mass369.816199 g/mol
Topological Polar Surface Area149 Ų
Heavy Atom Count15
Formal Charge2
Complexity131
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count4
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Ion Exchange Resins

High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ION EXCHANGE) with either cations or anions. (See all compounds classified as Ion Exchange Resins.)


API SUPPLIERS

read-more
read-more

01

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Metrochem

02

Lupin Manufacturing Solutions

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

03

Laurus Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Laurus Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

04

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

05

Macleods Pharmaceuticals Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Macleods Pharmaceuticals Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Sichuan Gowell Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Sichuan Gowell Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT arrow-down
blank

08

AstraZeneca

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

AstraZeneca

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

09

Viyash Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Viyash Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Apicore

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Apicore

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2022-04-18

Pay. Date : 2022-03-23

DMF Number : 36413

Submission : 2022-03-16

Status : Active

Type : II

Company Banner

02

Hetero Drugs Ltd

India

USDMF

arrow
AACR Annual meeting
Not Confirmed

02

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-04-19

Pay. Date : 2022-03-17

DMF Number : 36915

Submission : 2022-03-17

Status : Active

Type : II

blank

03

Laurus Labs Ltd

India

USDMF

arrow
AACR Annual meeting
Not Confirmed

03

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-01-28

Pay. Date : 2021-11-18

DMF Number : 36438

Submission : 2021-12-10

Status : Active

Type : II

blank

04

AACR Annual meeting
Not Confirmed

04

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-02-16

Pay. Date : 2022-01-13

DMF Number : 36363

Submission : 2021-12-07

Status : Active

Type : II

blank

05

AACR Annual meeting
Not Confirmed

06

AACR Annual meeting
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

AstraZeneca

United Kingdom
AACR Annual meeting
Not Confirmed
arrow

AstraZeneca

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

sodium zirconium cyclosilicate

Registrant Name : AstraZeneca Korea

Registration Date : 2025-11-28

Registration Number : Su248-21-ND

Manufacturer Name : AstraZeneca Pharmaceuticals ...

Manufacturer Address : 508 Wrangler Drive Coppell, TX 75019

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 11738044

Drug Substance Claim :

Drug Product Claim :

Application Number : 207078

Patent Use Code : U-2312

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-14

blank

02

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 9592253

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207078

Patent Use Code : U-2312

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-14

blank

03

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 8877255

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207078

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-22

blank

04

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 11738044

Drug Substance Claim :

Drug Product Claim :

Application Number : 207078

Patent Use Code : U-2312

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-14

blank

05

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 9913860

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207078

Patent Use Code : U-2312

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-22

blank

06

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 11406662

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207078

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-02-10

blank

07

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 9861658

Drug Substance Claim :

Drug Product Claim :

Application Number : 207078

Patent Use Code : U-2312

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-02-10

blank

08

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 10300087

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207078

Patent Use Code : U-2312

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-14

blank

09

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 8802152

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207078

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-19

blank

10

arrow
AACR Annual meeting
Not Confirmed

ASTRAZENECA

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

SODIUM ZIRCONIUM CYCLOSILICATE

US Patent Number : 9913860

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207078

Patent Use Code : U-2312

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-22

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for / Sodium Zirconium Cyclosilicate API manufacturers, exporters & distributors?

Sodium Zirconium Cyclosilicate manufacturers, exporters & distributors 1

70

PharmaCompass offers a list of Sodium Zirconium Cyclosilicate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium Zirconium Cyclosilicate manufacturer or Sodium Zirconium Cyclosilicate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Zirconium Cyclosilicate manufacturer or Sodium Zirconium Cyclosilicate supplier.

API | Excipient name

Sodium Zirconium Cyclosilicate

Synonyms

Uzsi 9, Zs-9 compound, Uzsi-9, Unii-d652zwf066, Zs 9

Sodium Zirconium Cyclosilicate Manufacturers

A Sodium Zirconium Cyclosilicate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Zirconium Cyclosilicate, including repackagers and relabelers. The FDA regulates Sodium Zirconium Cyclosilicate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Zirconium Cyclosilicate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sodium Zirconium Cyclosilicate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Sodium Zirconium Cyclosilicate Suppliers

A Sodium Zirconium Cyclosilicate supplier is an individual or a company that provides Sodium Zirconium Cyclosilicate active pharmaceutical ingredient (API) or Sodium Zirconium Cyclosilicate finished formulations upon request. The Sodium Zirconium Cyclosilicate suppliers may include Sodium Zirconium Cyclosilicate API manufacturers, exporters, distributors and traders.

click here to find a list of Sodium Zirconium Cyclosilicate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Sodium Zirconium Cyclosilicate USDMF

A Sodium Zirconium Cyclosilicate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Zirconium Cyclosilicate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Zirconium Cyclosilicate DMFs exist exist since differing nations have different regulations, such as Sodium Zirconium Cyclosilicate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Sodium Zirconium Cyclosilicate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Zirconium Cyclosilicate USDMF includes data on Sodium Zirconium Cyclosilicate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Zirconium Cyclosilicate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Sodium Zirconium Cyclosilicate suppliers with USDMF on PharmaCompass.

Sodium Zirconium Cyclosilicate KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Sodium Zirconium Cyclosilicate Drug Master File in Korea (Sodium Zirconium Cyclosilicate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sodium Zirconium Cyclosilicate. The MFDS reviews the Sodium Zirconium Cyclosilicate KDMF as part of the drug registration process and uses the information provided in the Sodium Zirconium Cyclosilicate KDMF to evaluate the safety and efficacy of the drug.

After submitting a Sodium Zirconium Cyclosilicate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sodium Zirconium Cyclosilicate API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Sodium Zirconium Cyclosilicate suppliers with KDMF on PharmaCompass.

Sodium Zirconium Cyclosilicate WC

A Sodium Zirconium Cyclosilicate written confirmation (Sodium Zirconium Cyclosilicate WC) is an official document issued by a regulatory agency to a Sodium Zirconium Cyclosilicate manufacturer, verifying that the manufacturing facility of a Sodium Zirconium Cyclosilicate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sodium Zirconium Cyclosilicate APIs or Sodium Zirconium Cyclosilicate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sodium Zirconium Cyclosilicate WC (written confirmation) as part of the regulatory process.

click here to find a list of Sodium Zirconium Cyclosilicate suppliers with Written Confirmation (WC) on PharmaCompass.

Sodium Zirconium Cyclosilicate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Zirconium Cyclosilicate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Sodium Zirconium Cyclosilicate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Sodium Zirconium Cyclosilicate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Sodium Zirconium Cyclosilicate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Zirconium Cyclosilicate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Sodium Zirconium Cyclosilicate suppliers with NDC on PharmaCompass.

Sodium Zirconium Cyclosilicate GMP

Sodium Zirconium Cyclosilicate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sodium Zirconium Cyclosilicate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium Zirconium Cyclosilicate GMP manufacturer or Sodium Zirconium Cyclosilicate GMP API supplier for your needs.

Sodium Zirconium Cyclosilicate CoA

A Sodium Zirconium Cyclosilicate CoA (Certificate of Analysis) is a formal document that attests to Sodium Zirconium Cyclosilicate's compliance with Sodium Zirconium Cyclosilicate specifications and serves as a tool for batch-level quality control.

Sodium Zirconium Cyclosilicate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Zirconium Cyclosilicate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sodium Zirconium Cyclosilicate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Zirconium Cyclosilicate EP), Sodium Zirconium Cyclosilicate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Zirconium Cyclosilicate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty